Snapshot from Jun 26, 2026 at 07:00 UTC. For live data and tracking: View Live
Entities / Sapu Nano
Other

Sapu Nano

Tracked across 1 events · 6 articles · First seen Jun 03, 2026 · Last active Jun 08, 2026

Sentiment
70
Attention
4
Events
1
Relationships
0
Live sentiment trends, attention charts, and prominence tracking available on the NewsDesk Dashboard
Events (1)
4 70
Business
Sapu Nano expands Sapu003 clinical trials
Sapu Nano announced the expansion of its Phase 1b clinical development program for Sapu003 (Everolimus for Injection), a proprietary intravenous formulation of everolimus. The program, which initially had an Australian clinical footprint, is now expanding…
Impact: Sapu Nano is expanding its Phase 1b clinical development program for Sapu003 and appointed Global Clinical Trials (GCT) as the lead CRO, which is a significant step towards global registrational studies and broader patient access.
Jun 03, 2026 · 6 articles
Key Actions (2)
100 Sapu Nano expanded clinical programSapu Nano expands Sapu003...
90 Sapu Nano appointed Global Clinical TrialsSapu Nano expands Sapu003...
NEWSDESK
Track Sapu Nano live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About NewsDesk

NewsDesk is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.newsdesk.dev.